Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.57158390 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.50769094 |
3 | locomotory exploration behavior (GO:0035641) | 5.34000431 |
4 | vocalization behavior (GO:0071625) | 5.19143684 |
5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.13525459 |
6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.02758945 |
7 | synaptic vesicle exocytosis (GO:0016079) | 4.94417982 |
8 | neuronal action potential propagation (GO:0019227) | 4.83114421 |
9 | glutamate receptor signaling pathway (GO:0007215) | 4.72329165 |
10 | glutamate secretion (GO:0014047) | 4.70934955 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59597353 |
12 | synaptic transmission, glutamatergic (GO:0035249) | 4.59499939 |
13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.57363229 |
14 | synaptic vesicle maturation (GO:0016188) | 4.55023411 |
15 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.48871367 |
16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.41279441 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.39089435 |
18 | protein localization to synapse (GO:0035418) | 4.33703552 |
19 | neuron-neuron synaptic transmission (GO:0007270) | 4.31489128 |
20 | gamma-aminobutyric acid transport (GO:0015812) | 4.27526372 |
21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.25302848 |
22 | cerebellar granule cell differentiation (GO:0021707) | 4.22027261 |
23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.21471076 |
24 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.13601874 |
25 | neuron cell-cell adhesion (GO:0007158) | 4.08281490 |
26 | cellular potassium ion homeostasis (GO:0030007) | 4.08232456 |
27 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.08232012 |
28 | neurotransmitter secretion (GO:0007269) | 4.07300234 |
29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.04440870 |
30 | long-term memory (GO:0007616) | 4.01862991 |
31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.98754233 |
32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.88717177 |
33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.88690487 |
34 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.85692772 |
35 | regulation of postsynaptic membrane potential (GO:0060078) | 3.84891997 |
36 | regulation of synapse structural plasticity (GO:0051823) | 3.84841955 |
37 | regulation of synaptic vesicle transport (GO:1902803) | 3.84408997 |
38 | exploration behavior (GO:0035640) | 3.79460912 |
39 | positive regulation of synapse maturation (GO:0090129) | 3.78052331 |
40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.76896649 |
41 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.75789083 |
42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71734312 |
43 | positive regulation of membrane potential (GO:0045838) | 3.71494468 |
44 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.71093058 |
45 | transmission of nerve impulse (GO:0019226) | 3.61318171 |
46 | sodium ion export (GO:0071436) | 3.54816189 |
47 | long-term synaptic potentiation (GO:0060291) | 3.54627996 |
48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50011850 |
49 | presynaptic membrane assembly (GO:0097105) | 3.49756448 |
50 | regulation of synaptic plasticity (GO:0048167) | 3.49702628 |
51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.43389734 |
52 | neurotransmitter transport (GO:0006836) | 3.36742153 |
53 | presynaptic membrane organization (GO:0097090) | 3.36362390 |
54 | negative regulation of cell killing (GO:0031342) | 3.36309997 |
55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36309997 |
56 | membrane depolarization during action potential (GO:0086010) | 3.36133986 |
57 | membrane depolarization (GO:0051899) | 3.33529686 |
58 | response to histamine (GO:0034776) | 3.30606653 |
59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.27276885 |
60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.26456007 |
61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.25507236 |
62 | cell communication by electrical coupling (GO:0010644) | 3.23572968 |
63 | L-amino acid import (GO:0043092) | 3.22053199 |
64 | long term synaptic depression (GO:0060292) | 3.21294925 |
65 | postsynaptic membrane organization (GO:0001941) | 3.20444622 |
66 | regulation of neurotransmitter secretion (GO:0046928) | 3.19426328 |
67 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.18815708 |
68 | membrane hyperpolarization (GO:0060081) | 3.18666876 |
69 | regulation of vesicle fusion (GO:0031338) | 3.15482440 |
70 | regulation of synapse maturation (GO:0090128) | 3.14388383 |
71 | neuromuscular process controlling balance (GO:0050885) | 3.13873326 |
72 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.13484102 |
73 | regulation of neurotransmitter levels (GO:0001505) | 3.13225774 |
74 | cellular response to epinephrine stimulus (GO:0071872) | 3.12679336 |
75 | auditory behavior (GO:0031223) | 3.10870732 |
76 | proline transport (GO:0015824) | 3.10647753 |
77 | synaptic vesicle endocytosis (GO:0048488) | 3.10626425 |
78 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09716309 |
79 | layer formation in cerebral cortex (GO:0021819) | 3.06099745 |
80 | neuron recognition (GO:0008038) | 3.04459739 |
81 | neuromuscular process controlling posture (GO:0050884) | 3.01695320 |
82 | dendritic spine morphogenesis (GO:0060997) | 3.01598622 |
83 | cell differentiation in hindbrain (GO:0021533) | 3.01104200 |
84 | activation of protein kinase A activity (GO:0034199) | 3.01026937 |
85 | response to auditory stimulus (GO:0010996) | 2.99563452 |
86 | learning (GO:0007612) | 2.99474157 |
87 | fear response (GO:0042596) | 2.97950247 |
88 | behavioral defense response (GO:0002209) | 2.97475692 |
89 | behavioral fear response (GO:0001662) | 2.97475692 |
90 | positive T cell selection (GO:0043368) | 2.96256220 |
91 | regulation of ARF protein signal transduction (GO:0032012) | 2.96192420 |
92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94378188 |
93 | regulation of neurotransmitter transport (GO:0051588) | 2.94307837 |
94 | synaptic transmission (GO:0007268) | 2.92321632 |
95 | detection of calcium ion (GO:0005513) | 2.91634015 |
96 | adult walking behavior (GO:0007628) | 2.91231632 |
97 | potassium ion import (GO:0010107) | 2.91112937 |
98 | mechanosensory behavior (GO:0007638) | 2.89357122 |
99 | regulation of synaptic transmission (GO:0050804) | 2.89296116 |
100 | startle response (GO:0001964) | 2.89275240 |
101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88263781 |
102 | positive regulation of synaptic transmission (GO:0050806) | 2.87454156 |
103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.86531828 |
104 | behavioral response to cocaine (GO:0048148) | 2.85370406 |
105 | axonal fasciculation (GO:0007413) | 2.85256800 |
106 | synapse assembly (GO:0007416) | 2.84966147 |
107 | glycine transport (GO:0015816) | 2.84468396 |
108 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84154051 |
109 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.83953599 |
110 | response to epinephrine (GO:0071871) | 2.83708352 |
111 | regulation of female receptivity (GO:0045924) | 2.82969562 |
112 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.82500497 |
113 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.82184790 |
114 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.80965541 |
115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.76449598 |
116 | cilium movement (GO:0003341) | 2.75925842 |
117 | activated T cell proliferation (GO:0050798) | 2.71720474 |
118 | cellular response to ethanol (GO:0071361) | 2.68314934 |
119 | negative regulation of type 2 immune response (GO:0002829) | 2.67777490 |
120 | positive thymic T cell selection (GO:0045059) | 2.67774156 |
121 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.64243635 |
122 | interkinetic nuclear migration (GO:0022027) | 2.60276228 |
123 | negative regulation of inclusion body assembly (GO:0090084) | 2.57253339 |
124 | axonemal dynein complex assembly (GO:0070286) | 2.54814835 |
125 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54186477 |
126 | microglial cell activation (GO:0001774) | 2.54135506 |
127 | lipid translocation (GO:0034204) | 2.52769333 |
128 | phospholipid translocation (GO:0045332) | 2.52769333 |
129 | negative T cell selection (GO:0043383) | 2.49892633 |
130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49338274 |
131 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47108480 |
132 | cellular response to interleukin-15 (GO:0071350) | 2.46869779 |
133 | nerve growth factor signaling pathway (GO:0038180) | 2.41781581 |
134 | positive regulation of Rap GTPase activity (GO:0032854) | 2.38705840 |
135 | macroautophagy (GO:0016236) | 2.38418173 |
136 | negative thymic T cell selection (GO:0045060) | 2.35730763 |
137 | regulation of Rap GTPase activity (GO:0032317) | 2.33976632 |
138 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.32446308 |
139 | positive regulation of phosphatase activity (GO:0010922) | 2.31660057 |
140 | regulation of beta-amyloid formation (GO:1902003) | 2.31618712 |
141 | growth hormone receptor signaling pathway (GO:0060396) | 2.31579101 |
142 | response to interleukin-15 (GO:0070672) | 2.31146500 |
143 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.30331743 |
144 | striated muscle atrophy (GO:0014891) | 2.28786969 |
145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.25146041 |
146 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.24709994 |
147 | establishment of protein localization to Golgi (GO:0072600) | 2.23135415 |
148 | negative regulation of B cell mediated immunity (GO:0002713) | 2.22190826 |
149 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.22190826 |
150 | import into cell (GO:0098657) | 2.20539344 |
151 | cellular response to monoamine stimulus (GO:0071868) | 2.20228424 |
152 | cellular response to catecholamine stimulus (GO:0071870) | 2.20228424 |
153 | * nucleus localization (GO:0051647) | 2.19712765 |
154 | cellular response to growth hormone stimulus (GO:0071378) | 2.17079886 |
155 | motile cilium assembly (GO:0044458) | 2.16721819 |
156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.16682055 |
157 | regulation of germinal center formation (GO:0002634) | 2.16100431 |
158 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.15776041 |
159 | B cell receptor signaling pathway (GO:0050853) | 2.15005806 |
160 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.14985921 |
161 | macrophage activation involved in immune response (GO:0002281) | 2.14631201 |
162 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.13190897 |
163 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.13190897 |
164 | protein K48-linked deubiquitination (GO:0071108) | 2.12898472 |
165 | relaxation of cardiac muscle (GO:0055119) | 2.12503411 |
166 | negative regulation of neurotransmitter transport (GO:0051589) | 2.11354034 |
167 | protein K11-linked deubiquitination (GO:0035871) | 2.11101628 |
168 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.10835858 |
169 | cyclic nucleotide catabolic process (GO:0009214) | 2.10069398 |
170 | skeletal muscle adaptation (GO:0043501) | 2.09965025 |
171 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.09196737 |
172 | regulation of cell communication by electrical coupling (GO:0010649) | 2.09078631 |
173 | cellular extravasation (GO:0045123) | 2.08543047 |
174 | response to monoamine (GO:0071867) | 2.04611776 |
175 | response to catecholamine (GO:0071869) | 2.04611776 |
176 | positive regulation of cation channel activity (GO:2001259) | 2.04177424 |
177 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.03945775 |
178 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.03352676 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45943174 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.83468010 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12699690 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02679991 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88401982 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61051900 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61051900 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55500696 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55305125 |
10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47653695 |
11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47021100 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46805391 |
13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43714714 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43135365 |
15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.40260527 |
16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38018002 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34025976 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29884381 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29081873 |
20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.28501660 |
21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.13636524 |
22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09694475 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05714122 |
24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03943919 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00678530 |
26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94446933 |
27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90906897 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90902195 |
29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84164208 |
30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82969103 |
31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81173986 |
32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79723284 |
33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76939585 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76649695 |
35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68257624 |
36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64459618 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57760957 |
38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56122002 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55905603 |
40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53327810 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50128845 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48963504 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42845036 |
44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41981827 |
45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.41368741 |
46 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40465831 |
47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37390190 |
48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37358175 |
49 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37062709 |
50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36081920 |
51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34599639 |
52 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34255008 |
53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.33924790 |
54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33090059 |
55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31867022 |
56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31558410 |
57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31009579 |
58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30970261 |
59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24773191 |
60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23961243 |
61 | * AR_19668381_ChIP-Seq_PC3_Human | 1.23801083 |
62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23387878 |
63 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23283368 |
64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22128875 |
65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21975379 |
66 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21376182 |
67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20420304 |
68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19900922 |
69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19457343 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19241794 |
71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18841924 |
72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18533536 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18143605 |
74 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16505570 |
75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15103047 |
76 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.14892089 |
77 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14797275 |
78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14262807 |
79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13621484 |
80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13515789 |
81 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12620996 |
82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12601717 |
83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12570047 |
84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12476674 |
85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09850846 |
86 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09328111 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07776768 |
88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07242572 |
89 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06747880 |
90 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06747880 |
91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06441911 |
92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06147918 |
93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05728197 |
94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04579602 |
95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03692634 |
96 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03529919 |
97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03315733 |
98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03268943 |
99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03144727 |
100 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02685911 |
101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02328863 |
102 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01322358 |
103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01043786 |
104 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99982116 |
105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99510594 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99473934 |
107 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99282512 |
108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98977662 |
109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98517974 |
110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98517974 |
111 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98320942 |
112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98290229 |
113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98225130 |
114 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97845650 |
115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96677808 |
116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96304433 |
117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96108391 |
118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95919321 |
119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95901028 |
120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95500178 |
121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95026190 |
122 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94864770 |
123 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94705552 |
124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94467759 |
125 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93497070 |
126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92551001 |
127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92422780 |
128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91634893 |
129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91112750 |
130 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89976397 |
131 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89249506 |
132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88807008 |
133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88329366 |
134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88063092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.22509444 |
2 | MP0003880_abnormal_central_pattern | 4.79490726 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.13426719 |
4 | MP0009046_muscle_twitch | 3.74342653 |
5 | MP0009745_abnormal_behavioral_response | 3.54769356 |
6 | MP0004270_analgesia | 3.33219890 |
7 | MP0002064_seizures | 3.27399071 |
8 | MP0002063_abnormal_learning/memory/cond | 3.24440204 |
9 | MP0001968_abnormal_touch/_nociception | 2.93173840 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.88552500 |
11 | MP0002272_abnormal_nervous_system | 2.81122083 |
12 | MP0002822_catalepsy | 2.72247729 |
13 | MP0001486_abnormal_startle_reflex | 2.67689262 |
14 | MP0005423_abnormal_somatic_nervous | 2.53279200 |
15 | MP0001501_abnormal_sleep_pattern | 2.52248345 |
16 | MP0004130_abnormal_muscle_cell | 2.50005579 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.46400352 |
18 | MP0002736_abnormal_nociception_after | 2.41254632 |
19 | MP0002735_abnormal_chemical_nociception | 2.36811748 |
20 | MP0001958_emphysema | 2.33529412 |
21 | MP0008569_lethality_at_weaning | 2.27203424 |
22 | MP0002067_abnormal_sensory_capabilities | 2.20603230 |
23 | * MP0001440_abnormal_grooming_behavior | 2.20408612 |
24 | MP0003724_increased_susceptibility_to | 2.00261887 |
25 | MP0003763_abnormal_thymus_physiology | 1.95022034 |
26 | MP0009780_abnormal_chondrocyte_physiolo | 1.90533657 |
27 | MP0001970_abnormal_pain_threshold | 1.86901567 |
28 | MP0002733_abnormal_thermal_nociception | 1.82130123 |
29 | MP0005646_abnormal_pituitary_gland | 1.79068616 |
30 | MP0004924_abnormal_behavior | 1.74446121 |
31 | MP0005386_behavior/neurological_phenoty | 1.74446121 |
32 | MP0002184_abnormal_innervation | 1.68212257 |
33 | MP0002557_abnormal_social/conspecific_i | 1.67483829 |
34 | MP0004145_abnormal_muscle_electrophysio | 1.66115508 |
35 | MP0003329_amyloid_beta_deposits | 1.61213191 |
36 | MP0002909_abnormal_adrenal_gland | 1.58698841 |
37 | MP0003879_abnormal_hair_cell | 1.55713661 |
38 | MP0000778_abnormal_nervous_system | 1.50535838 |
39 | MP0003633_abnormal_nervous_system | 1.49703226 |
40 | MP0004858_abnormal_nervous_system | 1.49379999 |
41 | MP0001502_abnormal_circadian_rhythm | 1.47634114 |
42 | MP0001984_abnormal_olfaction | 1.44200555 |
43 | MP0000955_abnormal_spinal_cord | 1.39126357 |
44 | MP0000751_myopathy | 1.38960601 |
45 | MP0004811_abnormal_neuron_physiology | 1.38613027 |
46 | * MP0002066_abnormal_motor_capabilities/c | 1.38387920 |
47 | MP0004142_abnormal_muscle_tone | 1.37935557 |
48 | MP0004885_abnormal_endolymph | 1.36938016 |
49 | MP0004883_abnormal_blood_vessel | 1.35047680 |
50 | MP0003690_abnormal_glial_cell | 1.34186870 |
51 | MP0003303_peritoneal_inflammation | 1.34132545 |
52 | * MP0002882_abnormal_neuron_morphology | 1.33098172 |
53 | MP0006276_abnormal_autonomic_nervous | 1.31886504 |
54 | MP0000015_abnormal_ear_pigmentation | 1.31792288 |
55 | MP0004084_abnormal_cardiac_muscle | 1.31597358 |
56 | MP0001188_hyperpigmentation | 1.30198709 |
57 | MP0003091_abnormal_cell_migration | 1.29652128 |
58 | MP0005551_abnormal_eye_electrophysiolog | 1.28596710 |
59 | MP0004215_abnormal_myocardial_fiber | 1.26964094 |
60 | * MP0002133_abnormal_respiratory_system | 1.25527647 |
61 | * MP0005388_respiratory_system_phenotype | 1.25527647 |
62 | MP0003631_nervous_system_phenotype | 1.24811062 |
63 | MP0002837_dystrophic_cardiac_calcinosis | 1.24738813 |
64 | MP0004381_abnormal_hair_follicle | 1.23911362 |
65 | MP0003828_pulmonary_edema | 1.23826790 |
66 | MP0002168_other_aberrant_phenotype | 1.22193829 |
67 | MP0003950_abnormal_plasma_membrane | 1.20947776 |
68 | MP0003787_abnormal_imprinting | 1.18667974 |
69 | MP0005503_abnormal_tendon_morphology | 1.14118383 |
70 | MP0005174_abnormal_tail_pigmentation | 1.13366054 |
71 | MP0001835_abnormal_antigen_presentation | 1.11142224 |
72 | MP0002229_neurodegeneration | 1.08341705 |
73 | MP0001800_abnormal_humoral_immune | 1.07950456 |
74 | MP0001529_abnormal_vocalization | 1.04091527 |
75 | MP0004742_abnormal_vestibular_system | 1.03099788 |
76 | MP0001905_abnormal_dopamine_level | 1.02882730 |
77 | MP0006082_CNS_inflammation | 1.01843645 |
78 | MP0003279_aneurysm | 1.01691011 |
79 | MP0003300_gastrointestinal_ulcer | 1.01412567 |
80 | MP0002152_abnormal_brain_morphology | 1.00750858 |
81 | MP0008872_abnormal_physiological_respon | 1.00671201 |
82 | MP0005645_abnormal_hypothalamus_physiol | 0.98692605 |
83 | MP0008874_decreased_physiological_sensi | 0.98025022 |
84 | MP0005164_abnormal_response_to | 0.97569633 |
85 | * MP0004085_abnormal_heartbeat | 0.96051924 |
86 | MP0005275_abnormal_skin_tensile | 0.95558006 |
87 | MP0000920_abnormal_myelination | 0.94597690 |
88 | MP0003632_abnormal_nervous_system | 0.93049587 |
89 | MP0002998_abnormal_bone_remodeling | 0.92235344 |
90 | MP0005595_abnormal_vascular_smooth | 0.91572134 |
91 | MP0001986_abnormal_taste_sensitivity | 0.90547172 |
92 | MP0004484_altered_response_of | 0.88838123 |
93 | MP0005409_darkened_coat_color | 0.88784972 |
94 | MP0005171_absent_coat_pigmentation | 0.88766672 |
95 | MP0001963_abnormal_hearing_physiology | 0.88034898 |
96 | MP0004043_abnormal_pH_regulation | 0.86422826 |
97 | MP0003172_abnormal_lysosome_physiology | 0.85910018 |
98 | MP0002090_abnormal_vision | 0.85819178 |
99 | MP0003866_abnormal_defecation | 0.85380481 |
100 | MP0005671_abnormal_response_to | 0.84348769 |
101 | MP0003656_abnormal_erythrocyte_physiolo | 0.84093628 |
102 | MP0010386_abnormal_urinary_bladder | 0.83197941 |
103 | MP0002876_abnormal_thyroid_physiology | 0.83010401 |
104 | MP0002295_abnormal_pulmonary_circulatio | 0.82735894 |
105 | MP0000013_abnormal_adipose_tissue | 0.82555975 |
106 | * MP0002069_abnormal_eating/drinking_beha | 0.81852939 |
107 | MP0005535_abnormal_body_temperature | 0.80523900 |
108 | MP0003075_altered_response_to | 0.79679040 |
109 | MP0000465_gastrointestinal_hemorrhage | 0.79535455 |
110 | MP0003634_abnormal_glial_cell | 0.79461167 |
111 | MP0001485_abnormal_pinna_reflex | 0.79432355 |
112 | MP0000569_abnormal_digit_pigmentation | 0.78627210 |
113 | MP0004510_myositis | 0.78312883 |
114 | * MP0003137_abnormal_impulse_conducting | 0.77851838 |
115 | MP0008057_abnormal_DNA_replication | 0.77828457 |
116 | MP0002638_abnormal_pupillary_reflex | 0.76837381 |
117 | MP0003122_maternal_imprinting | 0.74385477 |
118 | MP0002723_abnormal_immune_serum | 0.73701741 |
119 | MP0002405_respiratory_system_inflammati | 0.72690846 |
120 | MP0005167_abnormal_blood-brain_barrier | 0.72237992 |
121 | MP0002419_abnormal_innate_immunity | 0.72217190 |
122 | MP0005310_abnormal_salivary_gland | 0.71997037 |
123 | MP0001790_abnormal_immune_system | 0.71922077 |
124 | MP0005387_immune_system_phenotype | 0.71922077 |
125 | MP0002420_abnormal_adaptive_immunity | 0.71521783 |
126 | MP0003045_fibrosis | 0.70440473 |
127 | * MP0002752_abnormal_somatic_nervous | 0.69984077 |
128 | MP0002108_abnormal_muscle_morphology | 0.69688752 |
129 | MP0001299_abnormal_eye_distance/ | 0.69194124 |
130 | MP0004036_abnormal_muscle_relaxation | 0.67612188 |
131 | MP0000604_amyloidosis | 0.67386943 |
132 | MP0006072_abnormal_retinal_apoptosis | 0.66550939 |
133 | MP0004147_increased_porphyrin_level | 0.66494152 |
134 | MP0003646_muscle_fatigue | 0.64097026 |
135 | MP0000747_muscle_weakness | 0.64071337 |
136 | MP0005623_abnormal_meninges_morphology | 0.62946937 |
137 | * MP0001177_atelectasis | 0.61322757 |
138 | MP0004233_abnormal_muscle_weight | 0.59714385 |
139 | MP0005620_abnormal_muscle_contractility | 0.59656355 |
140 | MP0000749_muscle_degeneration | 0.58232859 |
141 | MP0003183_abnormal_peptide_metabolism | 0.57065504 |
142 | MP0001664_abnormal_digestion | 0.55066368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.29409096 |
2 | Myokymia (HP:0002411) | 6.12955428 |
3 | Focal seizures (HP:0007359) | 5.85722033 |
4 | Epileptic encephalopathy (HP:0200134) | 5.30039739 |
5 | Progressive cerebellar ataxia (HP:0002073) | 5.23286372 |
6 | Atonic seizures (HP:0010819) | 5.11373975 |
7 | Febrile seizures (HP:0002373) | 4.96845661 |
8 | Visual hallucinations (HP:0002367) | 4.70371741 |
9 | Action tremor (HP:0002345) | 4.54673224 |
10 | Gaze-evoked nystagmus (HP:0000640) | 4.43189256 |
11 | Absence seizures (HP:0002121) | 4.22177291 |
12 | Broad-based gait (HP:0002136) | 4.04248586 |
13 | Dialeptic seizures (HP:0011146) | 4.01388751 |
14 | Scanning speech (HP:0002168) | 3.98987036 |
15 | Dysdiadochokinesis (HP:0002075) | 3.97099553 |
16 | Hyperventilation (HP:0002883) | 3.91836327 |
17 | Generalized tonic-clonic seizures (HP:0002069) | 3.83153282 |
18 | Dysmetria (HP:0001310) | 3.63806576 |
19 | Impaired smooth pursuit (HP:0007772) | 3.54947629 |
20 | Dysmetric saccades (HP:0000641) | 3.52235026 |
21 | Genetic anticipation (HP:0003743) | 3.47641550 |
22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.40898544 |
23 | Truncal ataxia (HP:0002078) | 3.39404509 |
24 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.21915001 |
25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.21915001 |
26 | Hemiplegia (HP:0002301) | 3.19582319 |
27 | Poor eye contact (HP:0000817) | 3.17919941 |
28 | Rhinitis (HP:0012384) | 3.14682151 |
29 | T lymphocytopenia (HP:0005403) | 3.10341309 |
30 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.05056929 |
31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04927072 |
32 | Aortic aneurysm (HP:0004942) | 3.04892753 |
33 | Hemiparesis (HP:0001269) | 3.02578791 |
34 | Abnormal social behavior (HP:0012433) | 2.94359960 |
35 | Impaired social interactions (HP:0000735) | 2.94359960 |
36 | Abnormality of T cell number (HP:0011839) | 2.93247104 |
37 | Diplopia (HP:0000651) | 2.92428326 |
38 | Abnormality of binocular vision (HP:0011514) | 2.92428326 |
39 | Postural instability (HP:0002172) | 2.89828256 |
40 | Depression (HP:0000716) | 2.89276277 |
41 | Abnormality of the lower motor neuron (HP:0002366) | 2.87880329 |
42 | Supranuclear gaze palsy (HP:0000605) | 2.85975945 |
43 | Abnormal eating behavior (HP:0100738) | 2.84814156 |
44 | Intention tremor (HP:0002080) | 2.77947421 |
45 | Anxiety (HP:0000739) | 2.75496405 |
46 | Amblyopia (HP:0000646) | 2.73843904 |
47 | Status epilepticus (HP:0002133) | 2.72814084 |
48 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71520826 |
49 | Ventricular fibrillation (HP:0001663) | 2.67644138 |
50 | Nasal polyposis (HP:0100582) | 2.66580822 |
51 | Excessive salivation (HP:0003781) | 2.63706088 |
52 | Drooling (HP:0002307) | 2.63706088 |
53 | Bronchiectasis (HP:0002110) | 2.53776942 |
54 | Epileptiform EEG discharges (HP:0011182) | 2.44990474 |
55 | Eczematoid dermatitis (HP:0000976) | 2.42271212 |
56 | Abnormality of saccadic eye movements (HP:0000570) | 2.41778573 |
57 | Recurrent bronchitis (HP:0002837) | 2.38388187 |
58 | Abnormality of the nasal mucosa (HP:0000433) | 2.37715247 |
59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36262351 |
60 | Hyporeflexia of lower limbs (HP:0002600) | 2.36198299 |
61 | Protruding tongue (HP:0010808) | 2.35801527 |
62 | Stereotypic behavior (HP:0000733) | 2.35667764 |
63 | Abnormal ciliary motility (HP:0012262) | 2.34287514 |
64 | Ankle clonus (HP:0011448) | 2.31646617 |
65 | Spontaneous hematomas (HP:0007420) | 2.31321831 |
66 | Hyperkalemia (HP:0002153) | 2.29319550 |
67 | Impaired vibratory sensation (HP:0002495) | 2.28217029 |
68 | Absent frontal sinuses (HP:0002688) | 2.27249163 |
69 | Spastic gait (HP:0002064) | 2.26397117 |
70 | Syncope (HP:0001279) | 2.24312358 |
71 | Ocular albinism (HP:0001107) | 2.24171148 |
72 | Prolonged QT interval (HP:0001657) | 2.22069334 |
73 | Blue irides (HP:0000635) | 2.20086057 |
74 | Bradykinesia (HP:0002067) | 2.19609723 |
75 | Obstructive sleep apnea (HP:0002870) | 2.17903300 |
76 | Stomach cancer (HP:0012126) | 2.17890434 |
77 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.15732821 |
78 | Urinary urgency (HP:0000012) | 2.15673898 |
79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13616211 |
80 | Absent speech (HP:0001344) | 2.13173958 |
81 | Abnormality of the fingertips (HP:0001211) | 2.13098145 |
82 | Hypoplasia of the iris (HP:0007676) | 2.12920228 |
83 | Aortic dissection (HP:0002647) | 2.12800273 |
84 | Glucose intolerance (HP:0000833) | 2.10554644 |
85 | Fetal akinesia sequence (HP:0001989) | 2.08906083 |
86 | Annular pancreas (HP:0001734) | 2.08376054 |
87 | Gait ataxia (HP:0002066) | 2.03938001 |
88 | Incomplete penetrance (HP:0003829) | 2.02673360 |
89 | Gastrointestinal infarctions (HP:0005244) | 2.01857764 |
90 | Exercise-induced myalgia (HP:0003738) | 2.01530915 |
91 | Recurrent bacterial skin infections (HP:0005406) | 2.01442827 |
92 | Aplasia involving bones of the extremities (HP:0009825) | 2.01315781 |
93 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.01315781 |
94 | Aplasia of the phalanges of the hand (HP:0009802) | 2.01315781 |
95 | Chronic hepatic failure (HP:0100626) | 2.01066451 |
96 | Difficulty running (HP:0009046) | 2.01057497 |
97 | Muscle fiber splitting (HP:0003555) | 2.00510431 |
98 | Recurrent abscess formation (HP:0002722) | 1.99600167 |
99 | Abnormal EKG (HP:0003115) | 1.99574011 |
100 | Generalized hypopigmentation of hair (HP:0011358) | 1.99356608 |
101 | Absent/shortened dynein arms (HP:0200106) | 1.99335242 |
102 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99335242 |
103 | Cerebral aneurysm (HP:0004944) | 1.98604909 |
104 | Iris hypopigmentation (HP:0007730) | 1.97894727 |
105 | Neurofibrillary tangles (HP:0002185) | 1.96107055 |
106 | Bronchitis (HP:0012387) | 1.95072361 |
107 | Progressive inability to walk (HP:0002505) | 1.93989627 |
108 | Hypsarrhythmia (HP:0002521) | 1.93978901 |
109 | Overgrowth (HP:0001548) | 1.92852338 |
110 | Abnormality of the corticospinal tract (HP:0002492) | 1.91619875 |
111 | Generalized myoclonic seizures (HP:0002123) | 1.90350352 |
112 | Pheochromocytoma (HP:0002666) | 1.86849881 |
113 | Cerebral inclusion bodies (HP:0100314) | 1.86201421 |
114 | Interstitial pulmonary disease (HP:0006530) | 1.86030632 |
115 | Abnormality of incisor morphology (HP:0011063) | 1.85380372 |
116 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.85076988 |
117 | Decreased circulating renin level (HP:0003351) | 1.84505885 |
118 | Torticollis (HP:0000473) | 1.83771876 |
119 | Widely spaced teeth (HP:0000687) | 1.83202014 |
120 | Atrial fibrillation (HP:0005110) | 1.82978672 |
121 | Inability to walk (HP:0002540) | 1.82864611 |
122 | Retinal dysplasia (HP:0007973) | 1.82259697 |
123 | Postural tremor (HP:0002174) | 1.81954040 |
124 | Limb ataxia (HP:0002070) | 1.81527564 |
125 | Subacute progressive viral hepatitis (HP:0006572) | 1.79703466 |
126 | Psychosis (HP:0000709) | 1.79501643 |
127 | Bundle branch block (HP:0011710) | 1.79316753 |
128 | Lower limb muscle weakness (HP:0007340) | 1.79283574 |
129 | Chronic otitis media (HP:0000389) | 1.78944857 |
130 | Neoplasm of the heart (HP:0100544) | 1.78130225 |
131 | Primary atrial arrhythmia (HP:0001692) | 1.77203267 |
132 | Bradycardia (HP:0001662) | 1.76933742 |
133 | Striae distensae (HP:0001065) | 1.76418427 |
134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76263802 |
135 | Abnormality of salivation (HP:0100755) | 1.76189816 |
136 | Myositis (HP:0100614) | 1.75101738 |
137 | Focal dystonia (HP:0004373) | 1.74079690 |
138 | Spinal canal stenosis (HP:0003416) | 1.73735935 |
139 | Abnormality of eosinophils (HP:0001879) | 1.73686047 |
140 | Confusion (HP:0001289) | 1.73485982 |
141 | Sudden death (HP:0001699) | 1.73145283 |
142 | Megalencephaly (HP:0001355) | 1.72701996 |
143 | Arterial tortuosity (HP:0005116) | 1.71920959 |
144 | Gingivitis (HP:0000230) | 1.71294026 |
145 | Neuronal loss in central nervous system (HP:0002529) | 1.71061946 |
146 | Papilledema (HP:0001085) | 1.70972688 |
147 | Slow saccadic eye movements (HP:0000514) | 1.70927415 |
148 | Mutism (HP:0002300) | 1.70730846 |
149 | Retrobulbar optic neuritis (HP:0100654) | 1.69146239 |
150 | Optic neuritis (HP:0100653) | 1.69146239 |
151 | Peritonitis (HP:0002586) | 1.68118336 |
152 | Vascular tortuosity (HP:0004948) | 1.67574847 |
153 | Truncal obesity (HP:0001956) | 1.66950604 |
154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66142108 |
155 | Abnormal glucose tolerance (HP:0001952) | 1.64267621 |
156 | Hematochezia (HP:0002573) | 1.63952594 |
157 | Thyroiditis (HP:0100646) | 1.62890429 |
158 | Hypokalemic alkalosis (HP:0001949) | 1.59815449 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.80720862 |
2 | NTRK3 | 4.79888198 |
3 | FRK | 3.61573695 |
4 | CASK | 2.93864595 |
5 | MAP3K9 | 2.82465875 |
6 | TNIK | 2.67475981 |
7 | MAP3K4 | 2.66629500 |
8 | DAPK2 | 2.41781486 |
9 | MAP2K7 | 2.41157331 |
10 | NTRK2 | 2.23266092 |
11 | RIPK4 | 2.08987906 |
12 | MINK1 | 2.06619372 |
13 | CAMKK2 | 1.84244159 |
14 | PRPF4B | 1.77094655 |
15 | MAP2K4 | 1.71338483 |
16 | JAK1 | 1.71326073 |
17 | CDK19 | 1.68043364 |
18 | CAMKK1 | 1.66775705 |
19 | PAK6 | 1.66724571 |
20 | TAOK3 | 1.59696067 |
21 | MAP3K12 | 1.59312190 |
22 | KSR2 | 1.56200356 |
23 | BLK | 1.55264809 |
24 | FGFR2 | 1.54496716 |
25 | MARK1 | 1.52829692 |
26 | STK38 | 1.47209612 |
27 | PNCK | 1.43015948 |
28 | DAPK1 | 1.42444856 |
29 | PIK3CG | 1.42429669 |
30 | TXK | 1.42276964 |
31 | FES | 1.38964967 |
32 | PRKD3 | 1.38890894 |
33 | CDK5 | 1.38086602 |
34 | NTRK1 | 1.36337169 |
35 | TRPM7 | 1.35991491 |
36 | PLK2 | 1.35708745 |
37 | FGFR3 | 1.35616992 |
38 | MAP3K13 | 1.35007732 |
39 | KSR1 | 1.33574688 |
40 | PRKCG | 1.28497813 |
41 | SGK2 | 1.26377879 |
42 | OBSCN | 1.25466268 |
43 | CAMK1 | 1.22234423 |
44 | CAMK2A | 1.19603374 |
45 | CSK | 1.19513346 |
46 | SGK494 | 1.19038106 |
47 | SGK223 | 1.19038106 |
48 | GRK5 | 1.17917593 |
49 | MAPK13 | 1.17755247 |
50 | PTK2B | 1.13700466 |
51 | TGFBR2 | 1.12859694 |
52 | OXSR1 | 1.12060354 |
53 | SIK2 | 1.11794962 |
54 | CAMK2B | 1.11298799 |
55 | MARK2 | 1.10949726 |
56 | TTN | 1.08000168 |
57 | EPHA3 | 1.06464342 |
58 | PIK3CA | 1.06139798 |
59 | SYK | 1.04565925 |
60 | SGK3 | 1.02426731 |
61 | WNK1 | 1.01823228 |
62 | NLK | 0.99959805 |
63 | BMPR2 | 0.99261845 |
64 | GRK6 | 0.97441835 |
65 | MAP3K2 | 0.96642524 |
66 | IKBKE | 0.94773116 |
67 | TYK2 | 0.94280998 |
68 | ITK | 0.94241877 |
69 | BTK | 0.93955918 |
70 | ZAP70 | 0.93883289 |
71 | MAP4K1 | 0.93725323 |
72 | PHKG1 | 0.92491627 |
73 | PHKG2 | 0.92491627 |
74 | ARAF | 0.91532420 |
75 | PDGFRB | 0.91090146 |
76 | PRKCH | 0.89505218 |
77 | TEC | 0.88079408 |
78 | MAPK15 | 0.87951930 |
79 | SGK1 | 0.87335295 |
80 | AKT3 | 0.85208732 |
81 | PINK1 | 0.84560577 |
82 | STK11 | 0.83595367 |
83 | HCK | 0.82923370 |
84 | CAMK1G | 0.77444692 |
85 | TYRO3 | 0.76719208 |
86 | EPHB1 | 0.76299194 |
87 | MAP3K7 | 0.76052722 |
88 | MYLK | 0.76000041 |
89 | CAMK2D | 0.75545644 |
90 | LCK | 0.73502424 |
91 | MUSK | 0.73123196 |
92 | NEK6 | 0.72757298 |
93 | SIK3 | 0.72336104 |
94 | UHMK1 | 0.71435942 |
95 | CDK18 | 0.71344040 |
96 | INSRR | 0.71136281 |
97 | CDK15 | 0.68458643 |
98 | TNK2 | 0.67872229 |
99 | PDPK1 | 0.67746448 |
100 | CDC42BPA | 0.66450626 |
101 | JAK2 | 0.66325267 |
102 | CAMK4 | 0.66298307 |
103 | CAMK2G | 0.65947054 |
104 | JAK3 | 0.65176862 |
105 | PRKCE | 0.65155014 |
106 | PDK1 | 0.64652662 |
107 | DYRK1A | 0.64007191 |
108 | LMTK2 | 0.63027463 |
109 | RAF1 | 0.61773593 |
110 | RIPK1 | 0.60672994 |
111 | ERBB2 | 0.60551799 |
112 | CDK14 | 0.59074627 |
113 | PRKD1 | 0.58362757 |
114 | CDK11A | 0.57151019 |
115 | NEK9 | 0.56694145 |
116 | MAPK12 | 0.56533649 |
117 | FGR | 0.55977141 |
118 | RPS6KA3 | 0.55649085 |
119 | RET | 0.55152950 |
120 | ADRBK1 | 0.53977204 |
121 | MAP3K6 | 0.53236862 |
122 | PRKAA2 | 0.53225298 |
123 | PRKCQ | 0.52746886 |
124 | MAP2K3 | 0.52197970 |
125 | PAK3 | 0.51734393 |
126 | MELK | 0.51196698 |
127 | ACVR1B | 0.50574158 |
128 | PIM1 | 0.50310125 |
129 | MARK3 | 0.49982411 |
130 | FYN | 0.47853741 |
131 | DMPK | 0.47704244 |
132 | PRKG1 | 0.46272801 |
133 | KIT | 0.46093662 |
134 | MAP3K1 | 0.45652740 |
135 | HIPK2 | 0.45364026 |
136 | ROCK2 | 0.45343242 |
137 | CDK3 | 0.44951057 |
138 | MAPK7 | 0.44722452 |
139 | * PRKACA | 0.41635027 |
140 | CCNB1 | 0.40900433 |
141 | PRKCA | 0.38621351 |
142 | MAPK10 | 0.38385084 |
143 | GRK7 | 0.37141805 |
144 | PRKCB | 0.36404926 |
145 | PRKACB | 0.35416110 |
146 | NME1 | 0.34573534 |
147 | TAOK1 | 0.34037526 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.14663624 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.88472669 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.81730837 |
4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.81265691 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81033731 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76104486 |
7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65628165 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.57512626 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.52183631 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45537502 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.32563929 |
12 | Insulin secretion_Homo sapiens_hsa04911 | 2.04556245 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.01243260 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97080464 |
15 | Long-term depression_Homo sapiens_hsa04730 | 1.91350484 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88963411 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81738321 |
18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81592171 |
19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81105640 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75464247 |
21 | Renin secretion_Homo sapiens_hsa04924 | 1.73479007 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68049115 |
23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63582568 |
24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59592748 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53461736 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51445719 |
27 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.44305076 |
28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38164516 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36389234 |
30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34859533 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34214429 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31084180 |
33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24160265 |
34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22699550 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21449325 |
36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17572644 |
37 | Gap junction_Homo sapiens_hsa04540 | 1.17102370 |
38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12958661 |
39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10449808 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.07612917 |
41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05672495 |
42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05117058 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.05035495 |
44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05004817 |
45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03096553 |
46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02723758 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02148416 |
48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00049624 |
49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97114680 |
50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96451321 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94388903 |
52 | Axon guidance_Homo sapiens_hsa04360 | 0.94100863 |
53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87904201 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87371237 |
55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87045798 |
56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86625764 |
57 | Melanogenesis_Homo sapiens_hsa04916 | 0.84807984 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83851424 |
59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83205557 |
60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83068618 |
61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82718495 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81805805 |
63 | Glioma_Homo sapiens_hsa05214 | 0.80693736 |
64 | Focal adhesion_Homo sapiens_hsa04510 | 0.80358805 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79724568 |
66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77385832 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76264442 |
68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75529324 |
69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75363876 |
70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74836144 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74615486 |
72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73345785 |
73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72740773 |
74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71666865 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70118977 |
76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68850332 |
77 | Malaria_Homo sapiens_hsa05144 | 0.68832044 |
78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67555582 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67285716 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66891749 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65369872 |
82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65229003 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65073882 |
84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64608219 |
85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63475217 |
86 | Bile secretion_Homo sapiens_hsa04976 | 0.63327266 |
87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62522658 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61891143 |
89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61685303 |
90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60971480 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.60448567 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60305601 |
93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59694902 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.59541899 |
95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58456662 |
96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58235201 |
97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58117812 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57624105 |
99 | Tuberculosis_Homo sapiens_hsa05152 | 0.56655967 |
100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56367503 |
101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55095984 |
102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54119257 |
103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52513616 |
104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51654040 |
105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51379107 |
106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49760012 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49391926 |
108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48594698 |
109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47353948 |
110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44540466 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44275680 |
112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42789081 |
113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38022128 |
114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37219991 |
115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36859003 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36449013 |
117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35667475 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34975447 |
119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32259756 |
120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31621312 |
121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30931926 |
122 | Alcoholism_Homo sapiens_hsa05034 | 0.29006468 |
123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28003907 |
124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27560424 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26865060 |
126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26426423 |
127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26056561 |
128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25109905 |
129 | Endocytosis_Homo sapiens_hsa04144 | 0.24586148 |
130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22896879 |
131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22140415 |
132 | Platelet activation_Homo sapiens_hsa04611 | 0.21311282 |
133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20569272 |
134 | Mineral absorption_Homo sapiens_hsa04978 | 0.20002862 |